Christopher Lieu, MD
Christopher Lieu, MD, is the Co-Director of Gastrointestinal Medical Oncology at the University of Colorado Medicine.
Articles by Christopher Lieu, MD
Drs. Nataliya Uboha and Christopher Lieu highlight a recent analysis of the KRYSTAL-1 trial for metastatic colorectal cancer.
Dr. Christopher Lieu gives an overview of the BESPOKE trial and the GALAXY arm of CIRCULATE-Japan, as well as NETTER-2.
Dr. Lieu discusses the CIRCULATE-NORTH AMERICA trial on ctDNA status as a biomarker for risk stratification in colon cancer.
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024.
Drs. Vijayvergia and Lieu conclude with considerations for managing IO-related toxicities in patients with metastatic HCC.
Drs. Vijayvergia and Lieu continue their discussion with attention to biomarkers of response for immunotherapy in mHCC.
Drs. Vijayvergia and Lieu detail the considerations for administering immunotherapy to their patients with metastatic HCC.
Drs. Lieu and Lindquist provide an overview of the patient selection criteria for TACE and TARE in unresectable HCC.
Drs. Lieu and Lindquist detail the histories of TACE and TARE and why TARE may be more effective in treating uHCC.
Dr. Christopher Lieu talks about the upcoming liver cancer trials he has his eye on.
Dr. Christopher Lieu talks about the importance of liver cancer screening and educating patients about their risk factors.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.